Literature DB >> 16935931

Free radical scavenging inhibits STAT phosphorylation following in vivo ischemia/reperfusion injury.

James McCormick1, Sean P Barry, Ahila Sivarajah, Giorgio Stefanutti, Paul A Townsend, Kevin M Lawrence, Simon Eaton, Richard A Knight, Christoph Thiemermann, David S Latchman, Anastasis Stephanou.   

Abstract

The signal transducer and activator of transcription (STAT) family are latent transcription factors involved in a variety of signal transduction pathways, including cell death cascades. STAT1 has been shown to have a crucial role in regulating cardiac cell apoptosis in the myocardium exposed to ischemia/reperfusion (I/R) injury. The free radical scavenger, tempol, is known to have cardioprotective properties, although little is known about the molecular mechanism(s) by which it acts. In the present study, we assessed the levels of phosphorylated STAT1 and STAT3 and examined whether tempol was able to affect STAT activation after in vivo cardiac I/R injury. We observed a reperfusion time-dependent increase in the tyrosine phosphorylation of STAT1 and STAT3 at residues 701 and 705, respectively. Here we show for the first time that tempol dramatically reduced STAT1 and 3 phosphorylation. The reduction in STAT1 and 3 phosphorylation was accompanied by a concomitant decrease in cellular malondialdehyde (MDA) levels. To verify the role of STAT1 in modulating the cardioprotective effect of tempol, rats were injected with the STAT1 activator, IFN-gamma, and tempol during I/R injury. We found that the presence of IFN-gamma abrogated the protective effects of tempol, suggesting that the protective effects of tempol may partly operate by decreasing the phosphorylation of STAT1. This study demonstrates that careful dissection of the molecular mechanisms that underpin I/R injury may reveal cardioprotective targets for future therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16935931     DOI: 10.1096/fj.06-6188fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  25 in total

1.  STAT3 modulates the DNA damage response pathway.

Authors:  Seán P Barry; Paul A Townsend; Richard A Knight; Tiziano M Scarabelli; David S Latchman; Anastasis Stephanou
Journal:  Int J Exp Pathol       Date:  2010-08-27       Impact factor: 1.925

2.  Tempol protects the gallbladder against ischemia/reperfusion.

Authors:  Pedro J Gomez-Pinilla; Pedro J Camello; Jesus A F Tresguerres; María José Pozo
Journal:  J Physiol Biochem       Date:  2010-06-23       Impact factor: 4.158

3.  Activation of STAT1 in neurons following spinal cord injury in mice.

Authors:  Koji Osuka; Yasuo Watanabe; Nobuteru Usuda; Kimie Atsuzawa; Muneyoshi Yasuda; Chihiro Aoshima; Toshihiko Wakabayashi; Masakazu Takayasu
Journal:  Neurochem Res       Date:  2011-07-22       Impact factor: 3.996

4.  Activation of JAK-STAT and nitric oxide signaling as a mechanism for donor heart dysfunction.

Authors:  Christian F Bulcao; Karen M D'Souza; Ricky Malhotra; Michelle Staron; Jody Y Duffy; Prakash K Pandalai; Valluvan Jeevanandam; Shahab A Akhter
Journal:  J Heart Lung Transplant       Date:  2010-03       Impact factor: 10.247

5.  Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation.

Authors:  Paolo Santambrogio; Benedetta Gaia Erba; Alessandro Campanella; Anna Cozzi; Vincenza Causarano; Laura Cremonesi; Anna Gallì; Matteo Giovanni Della Porta; Rosangela Invernizzi; Sonia Levi
Journal:  Haematologica       Date:  2011-06-28       Impact factor: 9.941

Review 6.  STAT3 and cardiac remodeling.

Authors:  Arash Haghikia; Britta Stapel; Melanie Hoch; Denise Hilfiker-Kleiner
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

Review 7.  Effects of tempol and redox-cycling nitroxides in models of oxidative stress.

Authors:  Christopher S Wilcox
Journal:  Pharmacol Ther       Date:  2010-02-11       Impact factor: 12.310

8.  Protective effects of glycyrrhizin in a gut hypoxia (ischemia)-reoxygenation (reperfusion) model.

Authors:  Rosanna Di Paola; Marta Menegazzi; Emanuela Mazzon; Tiziana Genovese; Concetta Crisafulli; Martina Dal Bosco; Zhenzhen Zou; Hisanori Suzuki; Salvatore Cuzzocrea
Journal:  Intensive Care Med       Date:  2008-10-25       Impact factor: 17.440

Review 9.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

10.  STAT3 deletion sensitizes cells to oxidative stress.

Authors:  Seán P Barry; Paul A Townsend; James McCormick; Richard A Knight; Tiziano M Scarabelli; David S Latchman; Anastasis Stephanou
Journal:  Biochem Biophys Res Commun       Date:  2009-05-18       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.